Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 8,018 Cr.
- Current Price ₹ 1,222
- High / Low ₹ 1,654 / 960
- Stock P/E 53.5
- Book Value ₹ 165
- Dividend Yield 0.00 %
- ROCE 21.4 %
- ROE 22.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 7.41 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|
| 463 | 486 | 733 | 893 | 1,021 | |
| 379 | 419 | 580 | 691 | 794 | |
| Operating Profit | 84 | 67 | 153 | 201 | 227 |
| OPM % | 18% | 14% | 21% | 23% | 22% |
| 0 | 4 | 4 | 8 | 16 | |
| Interest | 26 | 39 | 44 | 42 | 36 |
| Depreciation | 26 | 31 | 36 | 39 | 42 |
| Profit before tax | 33 | 2 | 77 | 129 | 165 |
| Tax % | 10% | 248% | 34% | 43% | |
| 30 | -2 | 51 | 73 | 147 | |
| EPS in Rs | 5.83 | -0.45 | 10.05 | 12.90 | 24.14 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| TTM: | 45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| Last Year: | 23% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 |
| Reserves | 186 | 188 | 241 | 309 | 1,015 |
| 272 | 426 | 495 | 469 | 3 | |
| 94 | 124 | 122 | 151 | 142 | |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,226 |
| 435 | 630 | 684 | 720 | 716 | |
| CWIP | 10 | 26 | 27 | 29 | 39 |
| Investments | 2 | 7 | 3 | 2 | 2 |
| 156 | 126 | 195 | 235 | 470 | |
| Total Assets | 603 | 789 | 909 | 986 | 1,226 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| 74 | 123 | 137 | 176 | |
| -43 | -295 | -84 | -94 | |
| -32 | 184 | 32 | -51 | |
| Net Cash Flow | -1 | 12 | 85 | 31 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Debtor Days | 35 | 16 | 14 | 19 |
| Inventory Days | 64 | 48 | 39 | 44 |
| Days Payable | 268 | 217 | 157 | 164 |
| Cash Conversion Cycle | -169 | -152 | -104 | -101 |
| Working Capital Days | 39 | -4 | -9 | -17 |
| ROCE % | 7% | 17% | 21% |
Documents
Announcements
- Update on board meeting 2d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 May - Invite of the Earnings Conference Call for Investors/ Analysts to be held on Monday, 13th May, 2024 at 10.00 AM IST to discuss the operational …
- Board Meeting Intimation for To Consider And Approve The Audited Financial Results Along With The Audit Report Of The Company (Standalone And Consolidated) For The Quarter And Financial Year Ended On March 31, 2024 2 May
-
Compliance - Regulation 40(9) Of SEBI (LODR) Regulation, 2015
10 Apr - Certificate received from Practicing Company Secretary as required under Regulation 40 (9) of SEBI (LODR) Regulations, 2015
-
Compliance Certificate For The Year Ended March 31, 2024
6 Apr - Compliance certificate duly signed by the Compliance Officer of the Company and the authorized representative of the share transfer agent.
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.